SeekingAlpha · Feb 17, 2026
Lazard Equity Franchise Portfolio Q4 2025 Commentary
Lazard Equity Franchise Portfolio fell 6.6% in Q4, underperforming the MSCI World Index. Explore our analysis of top holdings like Fiserv and Cognizant now.
NASDAQ · LZFOX
Public company research
$7.31
Down-$0.06 (-0.81%)
Updated Sep 24, 2026, 6:52 PM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
LZFOX does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning LZFOX.
LZFOX research
Company profile and research snapshot.
The Portfolio invests primarily in equity securities, principally common stocks, of U.S. and non-U.S. companies, including those in emerging markets. It normally invests in equity securities listed on a national or other recognized securities exchange of companies that the Investment Manager considers to have an "economic franchise," meaning companies that have historically shown an ability to generate unleveraged returns, at or above their cost of capital, for long periods of time. The Portfolio may invest in the equity securities of any size company. It is non-diversified.
Consensus and target data currently published for this company.
No generated briefing is available yet.
SeekingAlpha · Feb 17, 2026
Lazard Equity Franchise Portfolio fell 6.6% in Q4, underperforming the MSCI World Index. Explore our analysis of top holdings like Fiserv and Cognizant now.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning LZFOX.
No results
No recent SID articles mention LZFOX.